Global Home Elevator Market Projected to Surpass US$ 21.8 Billion by 2033, With a 7.8% CAGR

The global home elevator market is on the verge of remarkable expansion, with revenues expected to reach an impressive US$ 10,266.9 million in 2023, and further accelerating at a robust CAGR of 7.8%. By the year 2033, the market is poised to reach an astonishing US$ 21,825.2 million. This extraordinary growth is being driven by various factors and innovations in the industry.

The increasing demand for home elevators can be attributed to the cutting-edge technologies implemented by leading companies, enhancing product efficiency and lifting capacity, which in turn has intensified competition within the home elevator market. Rapid urbanization, especially in emerging nations, has resulted in a surge in the construction of low- and high-rise buildings, key retail establishments, and various structures. This urban shift has led to an upsurge in the need for residential lifts, creating a favorable market environment.

Browse Full Report Here

Key Takeaways

  • The global home elevator market is set to reach US$ 10,266.9 million in 2023, with a projected CAGR of 7.8%, reaching US$ 21,825.2 million by 2033.
  • Rapid urbanization, property value enhancement, and technological innovations are primary drivers of market growth.
  • The United States market is experiencing significant expansion and investments, contributing to the global market surge.
  • Regulatory compliance and safety concerns remain key challenges in the industry.

Drivers and Opportunities

One of the primary drivers of this market surge is the heightened property value that comes with the inclusion of home elevators in smaller buildings and individual residences. As developers recognize the added value and benefits, they are increasingly eager to incorporate home elevators in their structures, thereby contributing to the overall global market share. Furthermore, the adoption of touchless operation has enhanced equipment efficiency and improved the overall user experience.

The integration of Internet of Things (IoT) and artificial intelligence (AI) is revolutionizing the interaction between users and elevators. This technological synergy is expected to generate lucrative prospects for the home elevator sector on a global scale throughout the projected period.

Competitive Landscape and Regional Trends

The competitive landscape in the home elevator market is undergoing significant transformation. With the United States being a prominent player, regional trends are worth noting. The United States region is experiencing remarkable growth in the home elevator market, in sync with the global trend. The market is witnessing substantial investments in research and development, leading to innovative solutions and a wide array of options for consumers.

Restraints

Despite the promising growth, the home elevator market is not without its challenges. Regulatory hurdles and safety concerns continue to be restraints, demanding stringent compliance with building codes and safety standards to ensure the well-being of users.

Region-wise Insights – Category-wise Insights

Region-wise, the United States is a burgeoning market within the home elevator sector, boasting a substantial market share. The adoption of home elevators in residential properties and commercial establishments is expanding rapidly, offering significant opportunities for market growth.

Category-wise, the residential segment holds a substantial portion of the market, with consumers increasingly recognizing the convenience and luxury associated with having home elevators.

Key Segments

By Type:

  • Hydraulic Elevator
  • Machine Room Less Elevator
  • Machine Room Elevator
  • Others

By Application:

  • Passengers
  • Freight

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Dual Axis Solar Trackers Market Targets a Valuation of US$ 24.8 Billion by 2033, Fueled by a Remarkable CAGR of 14.8%

The Dual Axis Solar Trackers Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the Dual Axis Solar Trackers market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for Dual Axis Solar Trackers. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The Dual Axis Solar Trackers Market is currently experiencing substantial growth, driven by increased government emphasis on renewable energy sources and the growing adoption of solar photovoltaic (PV) installations. Governments worldwide are redirecting their focus toward sustainable energy solutions, leading to a significant rise in demand for dual-axis solar trackers. These advanced tracking systems effectively enhance energy generation by dynamically aligning solar panels with the precise path of the sun, thereby optimizing solar exposure throughout the day.

Projections indicate that the global dual-axis solar tracker market is poised to reach a valuation of approximately US$ 6.3 billion by 2023. This growth can be attributed to the growing awareness of renewable energy sources, serving as a key driver for market expansion. Furthermore, estimations suggest that the market will achieve a total value of US$ 24.8 billion by 2033, reflecting a noteworthy compound annual growth rate (CAGR) of 14.8% from 2023 to 2033.

The increasing government focus on renewable energy sources, coupled with the rising deployment of solar PV systems, serves as significant catalysts for the upward trajectory of the dual-axis solar trackers market. Demonstrating their effectiveness, these dual-axis solar trackers are increasingly being embraced in large-scale solar power projects on a global scale. Their ability to yield higher energy output per unit of installed capacity makes them exceptionally well-suited for utility-scale installations and commercial solar farms.

Browse Full Report Here

The surge in energy demand has led to an increased need for augmented electricity production. Within this context, the adoption of dual-axis solar trackers is experiencing a significant upswing, especially in extensive solar projects. The increased deployment of these trackers, along with their advanced tracking algorithms, sensor integration, and control mechanisms, has greatly improved their precision and operational efficiency. These technological advancements have also resulted in enhanced reliability, cost efficiency, and seamless integration capabilities for dual-axis solar trackers. This positive trend is expected to drive substantial market growth in the foreseeable future.

The North American region has emerged as a prominent hub for ongoing technological innovation, playing a key role in the development of dual-axis solar tracker systems. These innovations have been instrumental in boosting energy output levels and strengthening system reliability. Consequently, dual-axis trackers have become an increasingly attractive option for solar projects in the region.

Key Takeaways:

  • The period from 2018 to 2022 experienced a substantial surge in demand for dual-axis solar trackers, demonstrating an impressive Compound Annual Growth Rate (CAGR) of 8.8%.
  • When categorized by type, the single-axis segment exhibited remarkable growth, contributing significantly to a CAGR of 14.4%.
  • An in-depth analysis based on application reveals that the utility segment is poised for substantial expansion, with a projected CAGR of 14.1% throughout the forecast duration.
  • The North American region is strategically positioned to emerge as a promising market for dual-axis solar trackers, boasting an anticipated CAGR of 14.7%.
  • Projections indicate that the dual-axis solar tracker industry in the United Kingdom is progressing steadily towards a significant milestone, expected to reach a valuation of US$ 1 billion by the year 2033.
  • Meanwhile, the dual-axis solar trackers market in South Korea is predicted to achieve substantial market revenue of US$ 1.3 billion by 2033.
  • The Asia Pacific region presents itself as an opportunistic market with an estimated CAGR of 14.6% during the projected forecast period.

 “Increased power demand globally and increasing technological innovation are expected to drive the market in the forecast period. The supportive government policies and increased use of renewable energy sources play a vital role in strengthening the market” – comments a lead analyst at FMI.

Competitive landscape:

  • Soitec,
  • First Solar, Inc.,
  • Reutech Radar Systems,
  • Targray Technology International Inc.
  • Trina Solar Co. Ltd.

among others are some of the market players operating in the dual-axis solar tracker market.

  • SunPower: Renowned solar energy enterprise with a notable presence in the dual-axis solar tracker sector.
    • Offers sophisticated dual-axis trackers seamlessly integrated with its premium high-efficiency solar panels.
    • Tracker systems meticulously engineered to optimize energy yield and elevate overall system efficiency.
    • SunPower’s foray into the dual-axis solar tracker domain bolsters the industry with proven expertise and credibility.
  • Arctech Solar: Prominent global manufacturer specializing in solar tracking and racking systems.
    • Recognized for its provision of dual-axis trackers celebrated for exceptional precision and dependable performance.
    • Extensively engaged in large-scale solar ventures across the globe, delivering tailored dual-axis tracking solutions for maximal energy production.

Know More about this Market Report:

Future Market Insights offers an unbiased analysis of the global dual-axis solar trackers market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the dual-axis solar trackers market, the market is segmented based on type and application across five major regions.

Key Segments:

By Type:

  • Single Axis
  • Dual Axis

By Application:

  • Utility
  • Non-Utility

By Region:

  • North American
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Explore this report from different publication

Dual axis solar tracker Market@ https://www.globenewswire.com/en/news-release/2023/06/08/2684474/0/en/The-Dual-Axis-Solar-Tracker-Market-is-projected-to-reach-a-valuation-of-US-24-8-Billion-by-2033-exhibiting-a-significant-CAGR-of-14-8-from-2023-to-2033-Future-Market-Insights.html

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

Global Seismic Protection Device Market Anticipates Surpassing US$ 2,220.8 Million by 2033, with a Steady 3.8% CAGR

The Seismic Protection Device Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the Seismic Protection Device market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for Seismic Protection Device. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The Seismic Protection Device Market is currently experiencing a surge in interest, driven by advancements in cutting-edge materials used in earthquake protection systems. Unlike traditional counterparts, specific materials such as shape memory alloys, fiber-reinforced composites, and high-performance damping materials are gaining significant attention for their exceptional properties. These materials not only enhance performance, durability, and flexibility but also signify a significant shift in our approach to seismic resilience.

According to Future Market Insights (FMI), the global market for seismic protection devices is poised to reach a value of US$ 1,525.4 million by 2023. Projections indicate that by 2033, its value will surpass US$ 2,220.8 million. During the assessment period spanning from 2023 to 2033, the market is expected to exhibit a compound annual growth rate (CAGR) of approximately 3.8%.

Browse Full Report Here

The seismic protection devices market is undergoing a notable integration of smart technologies and the Internet of Things (IoT). Manufacturers are now offering users real-time monitoring, data analysis, and remote control features, enabling the implementation of more effective and efficient earthquake protection systems.

The development and application of innovative materials in earthquake protection systems are garnering increased attention. Compared to conventional materials, materials such as shape memory alloys, fiber-reinforced composites, and high-performance damping materials offer superior performance, durability, and flexibility.

The importance of retrofitting seismic protection systems into existing structures is on the rise. Many infrastructures in various nations require updates to withstand seismic events, and retrofitting provides a means to enhance the resilience of these buildings without necessitating complete reconstruction.

Proactive and resilient infrastructure planning that integrates earthquake protection measures from the outset of the design and construction process is gaining prominence. This strategic approach involves the incorporation of seismic safety protocols into the infrastructure development process.

Suppliers are now offering comprehensive support services, encompassing architectural design, construction expertise, and urban planning, to ensure a more robust response to client requirements. This comprehensive approach contributes to client retention and satisfaction.

To provide real-time insights into the structural integrity of buildings and infrastructure, structural health monitoring systems are being seamlessly integrated with seismic protection equipment. This integration enhances the safety and reliability of structures, enables predictive maintenance, and facilitates early detection of potential issues.

Environmental and sustainability considerations are assuming greater significance within the seismic protection device industry. There is an enduring demand for environmentally friendly and energy-efficient solutions that minimize their ecological footprint while upholding performance and safety standards.

Key Takeaways:

  • In 2022, the two leading regions in the global seismic protection device market maintained a consistent market share of approximately 57.3%.
  • The global seismic protection device industry is forecasted to experience a Compound Annual Growth Rate (CAGR) of 3.8% during the assessment period from 2023 to 2033.
  • Within the product category, dampers are expected to maintain their dominant position, surpassing US$ 1345.3 million in revenue by the year 2033.
  • Notably, key participants in the seismic protection device industry collectively hold a substantial market share, accounting for approximately 50% to 55% of the total market.
  • In terms of application, the commercial segment is anticipated to maintain a significant market share, estimated at around 35% in the year 2023.

 “High seismicity areas have historically been concerned with seismic protection. However, there is a rising level of awareness and market expansion in earthquake-prone emerging areas. Necessity of making investments in seismic protection measures to guarantee the security of their infrastructure is being acknowledged by governments and organizations in these areas.” – says a lead analyst Future Market Insights (FMI)

Competitive Landscape:

Establishing robust customer relationships and delivering exceptional customer service are pivotal elements for achieving success within the industry. Companies that offer comprehensive support, encompassing engineering proficiency, adept project management, and unwavering maintenance services, can distinguish themselves distinctly from their competitors. The cultivation of resilient customer relationships and the cultivation of a reputation characterized by dependability and rapid responsiveness can culminate in recurring business engagements and valuable referrals.

The competitive landscape is not uniform and exhibits variations across different regions. Companies holding a prominent presence in seismically active areas such as Japan, the United States, and New Zealand may inherently possess a competitive edge. This advantage is primarily attributable to their geographical proximity and extensive experience in mitigating the distinctive challenges posed by local seismic conditions. Moreover, the competitive dynamics within specific regions are notably influenced by the prevailing local regulations and building codes in force.

For instance,

  • Sumitomo Metal Mining Siporex Co., Ltd, a company established in Japan, manufactures and sells equipment for controlling seismic vibration and isolation. SIPORIT, a seismic isolation system for buildings, and SICUBE, a seismic isolation system for bridges, are among the company’s offerings. In order to help clients, the corporation maintains a number of sales centers strategically positioned across the United States.

Find More Valuable Insights:

The research report analyzes the demand and trends of the global seismic protection device market. The market estimation and growth projection are based on factors such as end-use industries development, COVID-19 crisis impact, replacement ratio, and rate of urbanization.

As per Future Market Insights (FMI), the seismic protection device industry has been studied and segmented on the basis of product type (dampers, seismic joints, isolators), application (industrial, commercial, infrastructure), and regions. The report provides qualitative and quantitative information on various players in this market. This report also tracks the supply and demand sides of the market.

Key Segments:

By Product Type:

  • Dampers
    • Fluid Dampers
    • Silicon/Friction Dampers
    • Steel Hysteresis Dampers (SHD)
  • Seismic Joints
    • Flexible Joints
    • Expansion Joints
  • Isolators
    • Base Plate Isolator
    • Elastomeric Isolators
      • Natural Rubber (NRB)
      • Lead Rubber (LRB)
      • Tin Rubber (TRB)
      • High Damping (HDR)
      • Screw Down Non-return Globe Valves (SDNR)
    • Slider
      • ESL
      • SL
      • CSL
      • SLR

By Application:

  • Industrial
    • Exploration and Refineries
    • Aviation
    • Power Generation
    • Others
  • Commercial
    • Hotels
    • Data Storage Centers
    • Healthcare Institute
    • Fire Response
    • Offices
  • Infrastructure
    • Bridges
    • Residential High Rise Building
    • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Central Asia
  • South Asia and the Pacific
  • East Asia
  • Middle East & Africa

About Us

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

The Growing Impact of Biocontrol Agents in the Evolving Pest Control Services Market: From USD 23.26 Billion to USD 42.44 Billion by 2033

The pest control services market is expected to reach USD 23.26 billion in 2023 and grow to USD 42.44 billion by 2033

An important strategy in pest management is the growing development of biocontrol agents, which are used to reduce pest populations. These biological agents, consisting of naturally occurring organisms, are less harmful than many commonly used chemical pesticides. As a result, they are becoming increasingly integrated into the industry.

Manufacturing processes and environments in the environmental protection sector are governed by strict regulatory standards, which vary by country. Before pest control products can be used, they must be registered with pest control authorities, environmental protection agencies, and health organizations in each nation.

Market Opportunities

During the forecast period, the continued adoption of communication technologies like mobile phones and real-time video recorders is predicted to create great development prospects for the pest control services industry.

These communication solutions enable the suppliers of pest management services to gather information about the location and nature of pest issues in real-time. For instance, real-time communication tools like GoPro cameras record a specific pest issue and immediately link pest control experts to manage corrective action.

Key Takeaways

  • Sales of pest control services totaled US$ 20.7 billion in 2021. Between 2023 and 2033, FMI expects the agricultural category to increase by 50-150 basis points.
  • North America’s pest control services industry is likely to expand at a 5.2% CAGR by 2033. The demand for pest control services in the United States is predicted to increase at a healthy pace of 5.1% CAGR, according to FMI.
  • Due to increasing awareness of pest-borne diseases, the European market is expected to have a market share of 19.5% by 2033.
  • Chemical pest control is likely to hold a top spot regarding service type with a CAGR of 5.9% by 2033.
  • The insecticide segment is likely to hold a top spot based on the product, with a CAGR of 7% by 2033.
  • The residential sector holds nearly 35% of the global pest control service industry.
  • The growing popularity of Integrated Pest Management (IPM) in South Korea to preserve crops with less pesticide use is also helping to strengthen the market.

Competitors Winning Strategies

Pest control services businesses that provide cutting-edge, sustainable, and green pest management solutions that satisfy legal criteria and incorporate disease prevention are likely to enjoy the market expansion. Companies are creating innovative technology solutions to increase service effectiveness to acquire market share in the mature market.

Key Players

  • Rollins, Inc.
  • Rentokil Initial PLC
  • Anticimex
  • Cook’s Pest Control, Inc.
  • ABC Home & Commercial Services
  • Animal Pest Management Services, Inc.
  • Lloyd Pest Control
  • Green Earth Pest Control, LLC
  • Aptive Environmental, LLC
  • Home Paramount Pest Control, LLC
  • Dodson Pest Control
  • Environmental Pest Service, LLC
  • Truly Nolen of America, Inc.
  • Florida Pest Control & Chemical
  • Massey Services, Inc.
  • Arrow Exterminators
  • Ecolab, Inc.
  • Green Pest Solutions
  • Apex Pest Control, Inc.
  • Hulett Environmental Services
  • Plunkett’s Pest Control
  • Senske, Inc.

Recent Developments:

  • In May 2021, Anticimex Group, one of the world’s top pest control firms, revealed that it had acquired Palmera Junior, a Colombian family-owned business with a strong track record of expansion. To launch an expansion plan in this quickly expanding sector, Anticimex undertook the first strategic purchase in Latin America.
  • Several different crops can be protected using Spiropidion, a new innovative technology, from pests that are particularly harmful and challenging to control, according to Syngenta Crop Protection, a leading global crop protection organization, which announced the product’s launch in November 2020.

Key Segments

By Product:

  • Insecticides
  • Rodenticides
  • Other Chemicals
  • Mechanical
  • Other Products

By Service Type:

  • Chemical Control Services
    • Organic
    • Synthetic
  • Mechanical Control Services
  • Other Pest Control Services

By End-User:

  • Residential
  • Commercial and Industrial
  • Agricultural

By Application:

  • Rodent Control
  • Insect Control
    • Cockroaches
    • Ants
    • Bed Bugs
    • Termites
    • Mosquitoes
    • Wasps
    • Flies
    • Other Insect Control
  • Wildlife Control
    • Birds
    • Fleas
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website:https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hyperpigmentation Treatment Market to Reach USD 11.84 Billion in 2033, Projected to Grow at 9.5% CAGR Through 2033

Hyperpigmentation Treatment Market
Hyperpigmentation Treatment Market

The global hyperpigmentation treatment market is on track for substantial growth, with an estimated market value of USD 4.78 billion in 2023. According to recent projections, the market is expected to exhibit a robust compound annual growth rate (CAGR) of 9.5% from 2023 to 2033.

This impressive growth is driven by increasing awareness of skin conditions, advancements in treatment technologies, and a rising demand for effective solutions to manage hyperpigmentation. As more consumers seek to address skin discoloration issues and improve their overall appearance, the market for hyperpigmentation treatments is expanding rapidly.

Hyperpigmentation, a common skin condition characterized by darkened patches on the skin, is driving demand for a wide range of treatment options. This growth is attributed to rising awareness of skin health, advancements in treatment technologies, and a growing emphasis on cosmetic dermatology.

The popularity of the Hyperpigmentation Treatment Market is increasing due to a steady stream of new product releases and asset utilization by significant prominent stakeholders in research and development. Furthermore, rising demand for outpatient and microsurgical processes is anticipated to lead to lucrative opportunities in the Hyperpigmentation Treatment Market in the coming years. Furthermore, the global economy for hyperpigmentation Disorders Treatment may suffer as a result of insufficient favorable reimbursement and high demand for cosmetic procedures.

Dermabrasion practices, such as enhanced us ande of lasers in the diagnosis of pigmentation disorders and rising cosmetics spending globally, are expected to drive market growth. Researchers have been investigating how nanotechnology can improve active substance delivery and ingestion to the skin, in addition to the efficacy of specific therapeutic drugs. Because of its ability to improve the properties of skincare products in general, nanotechnology has emerged as a feasible addition to beauty products.

Key Takeaways from the Market Study

  • Hyperpigmentation Treatment market is predicted to exceed an impressive valuation of US$ 4.78 billion in 2023.
  • Sales increased significantly from 2018 to 2022, with a CAGR of 7.1%.
  • In 2021, Asia Pacific will account for approximately 36% of the global hyperpigmentation disorder services market.
  • The crystal microdermabrasion device segment in the United States is projected to expand at a CAGR of 9% during the forecast period.
  • The global Hyperpigmentation Treatment market is anticipated to be worth US$ 11.84 billion by 2033.

“Offering laser therapy and phototherapy to help the industry grow over the next few years. Moreover, automakers that treat hyperpigmentation illnesses have lucrative deals as a result of technological advances in cosmeceuticals and a boost in the use of pharmaceuticals in skincare.” says FMI’s analyst.

Key Market Players

Key players in the Hyperpigmentation Treatment market are Episciences, Vivier Pharma, La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, Obagi Medical Products, SkinCeuticals International, and L’Oréal Paris.

  • In September 2022, L’Oréal acquired Skinbetter Science, a practitioner U.S.-based skincare brand backed by cutting-edge dermatological science that combines internally developed efficacious additives with glamorous sensorial textures.
  • Obagi Medical Products introduced the Obagi Nu-Derm® Systems in October 2022, which help to convert skin by addressing hyperpigmentation and improving visible signs of aging.

A Old Full Report Analysis Click Here

Key Segments Profiled in the Hyperpigmentation Treatment Market Industry Survey

By Type:

  • Pharmacological Therapy
  • Laser Treatment
  • Chemical Peels and Bleach
  • Microdermabrasion
  • Skin Grafting or Plastic Surgery

By Application:

  • Skin Clinics
  • Drug and Cosmetic Stores
  • Hypermarkets and Supermarkets

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. 

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Dystrophic Epidermolysis Bullosa Management Market Projected to Reach USD 787.8 Million in 2033, Growing at 5.7% CAGR Through 2033

Dystrophic Epidermolysis Bullosa Management Market
Dystrophic Epidermolysis Bullosa Management Market

The global  dystrophic epidermolysis bullosa (DEB) management market is on a positive growth trajectory, with an expected market value of USD 452.37 million in 2023. The market is projected to exhibit a compound annual growth rate (CAGR) of 5.7% from 2023 to 2033.

This growth is primarily driven by the high prevalence of skin diseases and the increasing incidence of dystrophic epidermolysis bullosa, a rare but severe genetic condition that causes fragile skin prone to blistering. The rising demand for effective management solutions and ongoing advancements in treatment options are key factors contributing to the market’s expansion.

Dystrophic epidermolysis bullosa is a rare but severe genetic skin condition that causes fragile skin prone to blistering. The high incidence of this condition, combined with growing awareness and advancements in treatment options, are significant factors propelling the market’s growth.

Treatment for dystrophic epidermolysis bullosa involves a wound care regimen that integrates contemporary wound care techniques while eliminating factors that can irritate and inflame the skin. Dermatologists recommend adhering to strict personal hygiene habits and thoroughly moisturizing after treatments for dystrophic epidermolysis bullosa to promote healing of blisters without further damage or infection. Aqueous disinfectants are highly effective in treating DEB, and micro-adhesive silicone-based wound care is particularly useful for individuals with tough skin areas like elbows, shoulders, and trunks. Topical antibiotic ointments are expected to become the primary treatment for curing wounds and preventing the spread of infection in the future.

Various methods are being researched to treat EB, including the use of gene-corrected iPS cells from the patient’s own body, gene editing technologies, and polymer-mediated DNA delivery methods. Protein replacement therapies have been successful in treating several genetic diseases and could potentially be used to treat EB. A protein therapy approach involving intravenous and intradermal injections of recombinant collagen VII appears to be promising in treating DEB at the preclinical level, but further testing and development are necessary to determine its usefulness in treating patients.

Key Takeaways:

  • By 2023, global dystrophic epidermolysis bullosa management sales are expected to reach US$ 452.37 Million.
  • Antibiotics for dystrophic epidermolysis bullosa management are expected to grow 32% market share between 2023 and 2033.
  • Hospital pharmacies for the dystrophic epidermolysis bullosa management market are projected to grow at a CAGR of 3.4% from 2023 to 2033.
  • A market share of 23% is forecasted for the North American dystrophic epidermolysis bullosa management market.
  • European markets are projected to grow at a CAGR of 2.6% during the forecast period.

“The development of stem cell therapy, approval of new topical and oral medicines, and development of diagnostic devices will support the growth of dystrophic epidermolysis bullosa management market.” comments a Future Market Insights analyst.

Competitive Landscape :

Diagnostic techniques are increasingly being developed and researched in parallel as they advance. Several companies will likely expand their product lines, acquire other firms, or merge in the near future as new techniques and treatment emerge.

  • Abeona Therapeutics Inc. announced the completion of the final 6-month follow-up visit of its primary Phase 3 VIITAL trial of EB-101, the company’s targeted cell therapy investigation for dystrophic epidermolysis bullosa (RDEB). In order to lock the database within two to three weeks after the last patient’s final visit, Abeona has been verifying and preparing the data in real-time. As a result of the VIITAL study, Abeona intends to seek approval from the U.S. Food and Drug Administration (FDA) for EB-101 for the treatment of RDEB patients.
  • Researchers from Relief Therapeutics will test APR-TD011 on the effects of bacterial colonization on epidermolysis bullosa (EB) wounds in a pilot study. A chemical with strong antimicrobial properties, hypochlorous acid, is the active ingredient in the treatment. Buying Nexodyn helps cleanse and moisturize cuts, burns, and abrasions as well as acute wounds. In a trial that has been initiated by the investigator (NCT05533866), 15 patients with junctional EB or dystrophic EB and wounds infected with Staphylococcus aureus and/or Pseudomonas aeruginosa bacteria will be enrolled soon.

Key players:

Castle Creek Biosciences, Amryth Pharma, Krystal Biotech, Abeona Therapeutics, BridgeBio, Phoenix Tissue Repair, Wings Therapeutics, InMed Pharmaceuticals, Inc., Regenerx Biopharmaceuticals Inc., Holostem Terapie Avanzate S.r.l

More insights available

In North America and Europe, where there is a greater prevalence of the condition and higher levels of healthcare spending, there are more treatment options available. These options include wound care management, pain management, and gene therapy. The U.S. Food and Drug Administration (FDA) has approved several products for Dystrophic Epidermolysis Bullosa treatment, including a topical gel that helps to manage blistering and wound healing.

A Old Full Report Analysis Click Here

Key Segments:

By Disease Type:

  • Dominant Dystrophic Epidermolysis Bullosa (DDEB)
  • Recessive Dystrophic Epidermolysis Bullosa (RDEB)

By Drug Class:

  • Antibiotics
  • Corticosteroids
  • Opioid Analgesics
  • Anticonvulsant

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. 

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Podiatry Service Market Set for Steady Growth, Projected to Reach USD 6,077.7 Million by 2034 at a 3.6% of CAGR

Podiatry Service Market
Podiatry Service Market

The global podiatry service market is poised for steady growth, with an anticipated compound annual growth rate (CAGR) of 3.6% over the next decade. According to the latest market analysis, the market, valued at USD 4,845.2 million in 2024, is projected to expand to USD 6,077.7 million by 2034. The market was valued at USD 4,720.0 million in 2023.

The market is continuously expanding and includes services and treatments for illnesses, deformities, and injuries of the foot and ankle. The use of the MDT method to offer patients with integrated and comprehensive care has accelerated the acceptance of podiatry services in hospitals.

In addition, the podiatry association’s efforts to raise awareness, as well as existing hospitals and clinics seeking to improve the accessibility and availability of services, have aided market growth and awareness. The market for these services is growing in lockstep with the rise in diabetic, obese, and geriatric populations, as foot issues disproportionately affect these groups.

The market’s expansion is being fuelled by reasons such as the surge in disposable income, proactive attitude, and increased knowledge about foot care. The expansion of technology and trained resources, as well as initiatives by podiatry groups to increase the use and assist practitioners, have increased awareness of the services.

The rising incidence of foot disorders, particularly in the diabetic and elderly populations with 6.3% and 24%, respectively, as well as increased awareness and preventative approaches to children’s foot problems, are driving the market expansion. Furthermore, sportspersons’ use of specialized sports foot and ankle services for the treatment of foot and ankle injuries demonstrates the market potential for podiatry services in the sports area.

Competitive Analysis

The market is continuously expanding and includes services and treatments for illnesses, deformities, and injuries of the foot and ankle. The use of the MDT method to offer patients with integrated and comprehensive care has accelerated the acceptance of podiatry services in hospitals.

In addition, the podiatry association’s efforts to raise awareness, as well as existing hospitals and clinics seeking to improve the accessibility and availability of services, have aided market growth and awareness. The market for these services is growing in lockstep with the rise in the diabetic, obese, and geriatric population, as foot issues disproportionately affect these groups.

Some of the recent developments of key podiatry service providers are as follows:

  • In May 2022, Go 4-D, a firm established in Canada, stated that it would focus on data-driven and patient-centric research to aid in the creation of 3D-printed custom-made orthotics.
  • In April 2022, Kaiser Permanente announced a US$ 1 Billion investment to expand its reach in the United States by creating new clinics and acquiring companies to provide podiatry treatments.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Podiatry Services market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Type (General Podiatry, Podiatry surgery, Sports Podiatry and Podopediatrics), by Facility (Hospitals & Outpatient departments, Podiatry Offices/Clinics and Homecare & Telemedicine), across key regions (North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa).

A Old Full Report Analysis Click Here

Market Segments Covered in Podiatry Services Market Analysis

By Type:

  • General Podiatry
  • Podiatry surgery
  • Sports Podiatry
  • Podopediatrics

By Facility:

  • Hospitals & Outpatient departments
  • Podiatry Offices/Clinics
  • Homecare & Telemedicine

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global Prosthetics and Orthotics Market Expected to Surge to USD 12.2 Billion by 2033, Driven by 6% CAGR

Global Prosthetics and Orthotics Market
Global Prosthetics and Orthotics Market

Future Market Insights has unveiled a new report on the prosthetics and orthotics market, highlighting significant growth opportunities in the sector. The global market, valued at USD 6.5 billion in 2022, is projected to experience robust expansion, with an anticipated compound annual growth rate (CAGR) of 6% from 2023 to 2033. By the end of the forecast period, the market is expected to exceed USD 12.2 billion.

The report underscores the pivotal role of orthotics in driving market revenue, with this segment also expected to grow at a CAGR of approximately 6% over the next decade. This growth is fueled by advancements in prosthetic and orthotic technologies, increasing prevalence of orthopedic conditions, and a rising demand for personalized healthcare solutions.

Due to a range of benefits, including less pain and faster mobility recovery, upper limb orthotics accounted for the majority of the market. From 2021 to 2028, spinal orthotics is expected to grow at the fastest pace due to factors such as an increased incidence of spine injuries, a growing target population, and unhealthy lifestyles.

The rising senior demographic has become one of the main factors for the swelled demand for prosthetics and orthotics globally. According to the United Nations, the number of people aged 60 and over will more than double, from 962 million in 2017 to 2.1 billion in 2050. Elderly people are more vulnerable to such health conditions as osteoporosis and osteopenia, making them regular clients of orthopedic medications.

The increasing prevalence of osteosarcoma in young people and children is further upscaling the demand. The most common bone tumor in children is osteosarcoma. Osteosarcoma is typically treated with chemotherapy, surgery, and radiation. Post-operative treatment for patients recuperating from this procedure usually includes orthopaedic devices and prostheses.

In 2022, North America held a significant share of the global Prosthetics & Orthotics market. Government support for the Prosthetics and Orthotics sector’s development, a high level of awareness about cardiovascular and neurological disorders for an aging population, and increased awareness to spend on sports injuries are expected to propel the demand forward. Besides, easy access to high-quality medical facilities and attractive reimbursement policies are some of the key drivers of regional market growth.

Competitive Landscape

  • Ossur
  • Blatchford, Inc.
  • Fillauer LLC
  • Otto bock Healthcare GmbH
  • The Ohio Willow Wood Company
  • Ultraflex Systems
  • Steeper Group

Some of the recent developments of key Prosthetics and Orthotics providers are as follows:

  • In October 2022,Endolite announced that Linx, its fully integrated, microprocessor-controlled lower limb system has been awarded a German Design Award in the ‘Universal Design’ category.

A Old Full Report Analysis Click Here

Market Segments Covered in Prosthetics & Orthotics Market Analysis

By Type:

  • Prosthetics
    • Upper Extremity
    • Lower Extremity
    • Liners
    • Sockets
    • Modular Components
  • Orthotics
    • Upper Limb
    • Lower Limb
    • Spinal

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Cytokine Release Syndrome Management Market Set to Reach USD 44.6 Billion by 2023, Projected to Grow at 6.7% CAGR Through 2033

Cytokine Release Syndrome Management Market
Cytokine Release Syndrome Management Market

The global cytokine release syndrome (CRS) management market is on track for substantial growth, with an estimated market value of USD 23.32 billion in 2023. According to the latest projections, the market is expected to exhibit a compound annual growth rate (CAGR) of 6.7% from 2023 to 2033.

This significant growth is attributed to the increasing incidence of autoimmune diseases and cancers, which are driving the demand for effective CRS management solutions. As the prevalence of these conditions continues to rise, the need for advanced therapies and management strategies for CRS is becoming more critical.

Cytokine release syndrome, a severe and potentially life-threatening condition, is often associated with immune therapies, such as CAR-T cell therapy, used in cancer treatment. As the use of these therapies expands, so too does the demand for effective CRS management solutions. This trend is expected to drive significant growth in the CRS management market over the next decade.

As cancer rates rise and treatment options for CRS increase, the market will continue to expand. For instance, Harpoon Therapeutics, Inc., is developing novel T-cell engagers in clinical trials. The 64th American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans presents updated interim data from the Phase 1 clinical trial evaluating HPN217 in relapsed/refractory multiple myeloma (RRMM). Based on Harpoon’s proprietary TriTAC ® platform, HPN217 targets B-cell maturation antigens (BCMA) to bring patients’ own immune cells to the tumor.

FDA approvals of various therapeutics and drugs have further enhanced the market. Further studies and tests funded by the government will increase awareness of CRS management by clinical professionals. For instance, mosunetuzumab-axgb (Lunsumio; Genentech) was approved by the FDA for the treatment of adults with R/R follicular lymphoma. As of July 2022, mosunetuzumab had been granted priority review by the FDA for the treatment of R/R FL. High and durable responses were demonstrated in the phase 2 GO29781 study (NCT02500407), which supported the decision. The continued approval of this product is dependent on a confirmatory trial verifying clinical benefit since this is an accelerated approval.

Key Takeaways from the Market Study 

  • Globally, the cytokine release syndrome management market is expected to reach US$ 23.32 billion by 2023.
  • Hospitals for cytokine release syndrome management are expected to grow 32% market share between 2023 and 2033.
  • The market for Tumour Necrosis Factor-TNF is projected to grow by 2.9% from 2023 to 2033.
  • Cytokine release syndrome management in North America expanded with a market share of 17% during the forecast period.
  • According to forecasts, the arthritis therapeutics market accumulate a share of 19% over the next few years.

“Advances in immunotherapies, the approval of new drugs, and CAR T-cell therapies are expected to further accelerate the growth of the cytokine release syndrome management market.” comments a Future Market Insights analyst.

Competitive Landscape 

The development of innovative diagnostic techniques is becoming increasingly important for companies, which will probably lead to a number of firms expanding their product lines, acquiring other companies, or merging their companies in the near future, as many are likely to focus on developing new diagnostic techniques.

  • Kite announced that the Food and Drug Administration (FDA) has approved the addition of prophylactic corticosteroids to the prescribing information for Yescarta®. The label on Yescarta includes information to guide physicians in managing and possibly preventing side effects associated with chimeric antigen receptor (CAR) T-cell therapies. To maximize the chances of CAR T-cell therapy being beneficial to as many patients as possible, Kite has been working closely with physicians since Yescarta’s first approval in 2012. CAR T therapy research is also focused on expanding into new diseases and early treatment lines, while continuously enhancing the safety and efficacy of existing treatments.
  • Nexcella, Inc., a subsidiary of Immix Biopharma, Inc., reported stable response rates among 6 patients with relapsed/refractory AL amyloidosis using NXC-201. Six relapsed/refractory AL amyloidosis patients treated with NXC-201 have shown 100% complete response. Using clinical cancer research, 100% complete responses were observed; 100% organ responses were observed; and at 5.2 months, the duration of response was still unknown, resulting in an average reduction of 65% (2,656 pg/mL) in NT-proBNP from baseline. There was no grade 4 Cytokine Release Syndrome. ICANS neurotoxicity was not observed; NYHA stage improved by 2 stages.

Key Companies Profiled:

  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Novartis AG
  • Sanofi S.A
  • Pfizer Inc.
  • Bayer AG
  • Biocon
  • AbbVie Inc.
  • Johnson & Johnson Private Limited
  • Incyte Corporation
  • Swedish Orphan Biovitrum
  • Genentech

A Old Full Report Analysis Click Here

Key Segments Profiled in the Cytokine Release Syndrome Management Industry Survey?

By Cytokine Type:

  • Tumor Necrosis Factor-TNF
  • Interleukins-II
  • Interferons-IFN
  • Epidermal Growth Factor-EGF

By Therapeutic Application:

  • Cancer
  • Asthma
  • Airway Inflammation
  • Arthritis
  • Others

By Biomarker Type:

  • Interleukin-10
  • Interferon Gamma
  • Interleukin-6
  • Ferritin
  • Cluster of Differentiation-163

By Route of Administration:

  • Oral
  • Intravenous

By End User:

  • Hospitals
  • Specialty Clinics
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global Biosensors Market Poised for Robust Growth, Projected to Reach USD 24.5 Billion by 2033

Global Biosensors Market
Global Biosensors Market

Future Market Insights has released a comprehensive analysis of the biosensors market, revealing a substantial increase in market size and growth prospects. The global biosensors market was valued at USD 24.5 billion in 2022 and is anticipated to experience a significant upward trajectory with a compound annual growth rate (CAGR) of 9.5% from 2023 to 2033.

The market’s expansion is expected to be driven by advancements in biosensor technologies and increased applications across various sectors, including healthcare, environmental monitoring, and industrial processes. Among the different segments, medical biosensors are projected to be the highest revenue-generating category. This segment is expected to grow at an impressive CAGR of over 10.5% during the forecast period, reflecting the rising demand for advanced diagnostic and monitoring solutions in healthcare.

The biosensors market is being driven by an increase in chronic illnesses such as diabetes, an increase in biotechnology research and development, and an increase in demand for homecare equipment. The increased use of biosensors in glucose monitoring systems has resulted in market expansion. However, market growth is expected to be hampered by the high costs associated with these devices, as well as a lack of willingness to embrace new treatment devices. Improvements in biosensor technology, on the other hand, that add portability, are expected to drive market growth.

Nanotechnology-based biosensors are expected to be profitable in a variety of industries, including food analysis, imaging operations, and microbial activity monitoring. The market is consolidating as a result of the increasing popularity of medical equipment and customised drugs, as well as a greater demand for non-invasive biosensors and increased research collaboration and agreements among various producers.

Because of their ability to assess fitness as well as the onset and progression of illness, biosensors are widely used in home-based healthcare by patients. As a result, the market is expected to expand throughout the forecast period. A variety of non-medical activities, as well as technological advancement, are expected to broaden its applicability and, as a result, support its growth. Pregnancy testing, cholesterol testing, blood glucose testing, and drug detection are some of the healthcare services that are expected to have a positive market impact.

Competitive Analysis

Because of the increased demand for biosensors, global manufacturers are accelerating and improving their manufacturing processes by implementing cost-effective solutions. A few of the key players in the biosensors market include Bio-Rad Laboratories Inc., Medtronic, Abbott Laboratories, Biosensors International Group, Ltd., Pinnacle Technologies Inc., Ercon, Inc., DuPont Biosensor Materials, Johnson & Johnson, Koninklijke Philips N.V., LifeScan, Inc., QTL Biodetection LLC, Molecular Devices Corp., Nova Biomedical, Molex LLC, TDK Corporation, Zimmer & Peacock AS, and Siemens Healthcare.

Some of the recent developments of key Biosensors providers are as follows:

  • In January 2022, Roche and Sysmex agreed to a Global Business Partnership (GBP) to provide haematological diagnostic services. The new collaboration will use IT technology to improve clinical decision-making and the consumer experience. This long-running, fruitful collaboration is still going strong, providing haematological diagnostic improvements to labs worldwide.
  • In December 2020, Abbott announced that FreeStyle Libre 2, its next-generation sensor-based glucose monitoring device, has been approved by Health Canada for adults and children (4 years and older) with diabetes.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Biosensors Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Product Type (Medical, Food Toxicity, Bioreactor, Agriculture, Environment and Others), Technology (Thermal, Electrochemical, Piezoelectric and Optical), End-Use (Home Healthcare Diagnostics, PoC Testing, Food Industry, Research Laboratories and Security & Biodefence) and across key regions (North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa).

A Old Full Report Analysis Click Here

Market Segments Covered in Biosensors Market Analysis :

By Product Type:

  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood Gas Analyzer
    • Pregnancy Testing
    • Drug Discovery
    • Infectious Disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others

By Technology:

  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical

By End-Use:

  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security & Biodefense

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube